Cell Point (India)NSE:CELLPOINT 71 Days Payable is 17.78 as of Mar. 2026, which is 6% below its 10-year median of 18.83. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 71/100 and a GF Value™ of ₹34.72 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 1,098 Retail - Cyclical companies, Cell Point (India) ranks worse than 84.7% on this metric.
The historical rank and industry rank for Cell Point (India)'s Days Payable or its related term are showing as below:
NSE:CELLPOINT'
s Days Payable Range Over the Past 10 Years
Min: 14.06 Med: 18.83 Max: 21.53
Current: 17.89
During the past 7 years, Cell Point (India)'s highest Days Payable was 21.53. The lowest was 14.06. And the median was 18.83.
NSE:CELLPOINT's Days Payable is ranked worse than 84.7% of 1098
companies
in the Retail - Cyclical industry
Industry Median: 51.625
vs NSE:CELLPOINT: 17.89
Cell Point (India)'s Days Payable
declined
from Mar. 2025 (18.01) to Mar. 2026 (17.78).
It may suggest that Cell Point (India)accelerated paying its suppliers.
Cell Point (India) Days Payable Related Terms
Cell Point (India) Days Payable Historical Data
* Premium members only.
The historical data trend for Cell Point (India)'s Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CELLPOINT vs CASY, WSM, DKS: Days Payable Comparison
For the Specialty Retail subindustry, Cell Point (India)'s Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cell Point (India) Days Payable vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Cell Point (India)'s Days Payable distribution charts can be found below:
* The bar in red indicates where Cell Point (India)'s Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cell Point (India)'s Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Point (India) (NSE:CELLPOINT) has a Days Payable of 17.78 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cell Point (India) and its competitors. This is near median its historical median of 18.83. Over the past decade, Cell Point (India)'s Days Payable has ranged from 14.06 to 21.53. According to the industry distribution chart, Cell Point (India) ranks #930 out of 1098 companies in the Retail - Cyclical industry, placing it in the top 84.7%.
Is Cell Point (India)'s Days Payable too high?
Cell Point (India)'s current Days Payable of 17.78 is near median its 10-year median of 18.83. Over the past 10 years, this metric has ranged from a low of 14.06 to a high of 21.53. The Retail - Cyclical industry median Days Payable is 51.63. Cell Point (India)'s value of 17.78 is 65.6% below this industry median. Based on the distribution chart, Cell Point (India) ranks #930 out of 1098 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Cell Point (India) has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s Days Payable compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Cell Point (India) ranks #930 out of 1098 companies for Days Payable. This places Cell Point (India) in the lower half of its industry. The industry median Days Payable is 51.63. Cell Point (India)'s value of 17.78 is 65.6% below this benchmark. Historically, Cell Point (India)'s own Days Payable has ranged from 14.06 to 21.53 over the past decade. While the company's 10-year median is 18.83 vs. the industry median of 51.63, Cell Point (India) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Retail - Cyclical company?
The median Days Payable among Retail - Cyclical companies is 51.63, based on 1,098 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cell Point (India)'s current Days Payable of 17.78 is 65.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cell Point (India) and its competitors. For the Retail - Cyclical industry, the median Days Payable is 51.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Point (India)'s current Days Payable is 17.78, which is near median its own 10-year median of 18.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹34.72, compared to a current price of ₹15.00 — trading 56.8% below its estimated fair value. The current Days Payable is 17.78, which is near median its 10-year median of 18.83 and 65.6% below the Retail - Cyclical industry median of 51.63. Cell Point (India)'s overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current Days Payable is 17.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?
Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued.
The current stock price of ₹15.00 is trading 56.8% below its estimated GF Value™ of ₹34.72.
GuruFocus considers Cell Point (India) to be Significantly Undervalued.
Key valuation signals for NSE:CELLPOINT:
Days Payable: 17.78 (near median its 10-year median of 18.83)
GF Value™: ₹34.72 vs. price of ₹15.00 (56.8% below fair value)
Industry Position: 65.6% below the Retail - Cyclical median (#930 of 1098)
No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
71GF Score
Get the complete analysis for NSE:CELLPOINT
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CELLPOINT has been successfully added to your 
